AUTHORS
Howard Liebman
Professor of Medicine, Director of Fellowship Program in Hematology at Division of Hematology, Norris Comprehensive Cancer Center(Los Angeles, CA, USA).
Professor Liebman is on the forefront of research in thrombotic and hemorrhagic disorders. He and his team are currently studying the genetic risk factors responsible for thrombotic diseases, including venous thrombosis, pulmonary embolism, arterial thrombosis and thrombosis associated with cancer chemotherapy. He has also been the principle investigator on a number of clinical trials in the management of immune thrombocytopenia.
Professor Liebman has authored or co-authored over 100 medical articles and chapters and has led well over a hundred lectures across the USA, South America, Europe and Japan on a variety of medical topics.
Professor Liebman is on the forefront of research in thrombotic and hemorrhagic disorders. He and his team are currently studying the genetic risk factors responsible for thrombotic diseases, including venous thrombosis, pulmonary embolism, arterial thrombosis and thrombosis associated with cancer chemotherapy. He has also been the principle investigator on a number of clinical trials in the management of immune thrombocytopenia.
Professor Liebman has authored or co-authored over 100 medical articles and chapters and has led well over a hundred lectures across the USA, South America, Europe and Japan on a variety of medical topics.